Bone and lymph node metastases from neuroblastoma detected by 18F-DOPA-PET/CT and confirmed by posttherapy 131I-MIBG but negative on diagnostic 123I-MIBG scan

Clin Nucl Med. 2014 Jan;39(1):e80-3. doi: 10.1097/RLU.0b013e31827a0002.

Abstract

We report the case of a 6-year-old child with stage 4 neuroblastoma, previously treated with chemotherapy, which relapsed in the right mandibular branch, right submandibular lymph nodes, and bone marrow. These sites of recurrence were detected on diagnostic (123)I-MIBG and confirmed by (18)F-DOPA-PET/CT, which revealed the following 2 additional sites of disease: in the skull base and the left supraclavicular lymph nodes. The patient was scheduled for radioiodine therapy and received a total dose of 7400 MBq (200 mCi) of (131)I-MIBG. The whole-body scan, acquired 72 hours later, revealed all sites of disease detected by (18)F-DOPA-PET/CT, including those negative on (123)I-MIBG scan.

Publication types

  • Case Reports

MeSH terms

  • 3-Iodobenzylguanidine*
  • Bone Neoplasms / diagnosis*
  • Bone Neoplasms / secondary
  • Child
  • Dihydroxyphenylalanine / analogs & derivatives*
  • Humans
  • Lymphatic Metastasis
  • Male
  • Multimodal Imaging*
  • Neuroblastoma / pathology*
  • Neuroblastoma / therapy
  • Positron-Emission Tomography*
  • Tomography, X-Ray Computed*

Substances

  • fluorodopa F 18
  • 3-Iodobenzylguanidine
  • Dihydroxyphenylalanine